Product Center
STAR PRODUCTS

The first approval double antibody sandwich method Novel coronavirus (2019-nCoV) antibody detection reagent in the world

National emergent approval product

Have performance certification by multiple national authorizations

High sensitivity,specificity, and celerity of test result; many asymptomatic patients were detected under the condition that nucleic acid was negative, strengthening the epidemic controlling net

Caris200 Series、Wan200+ Series 2019-nCoV Ab
Copyright  2022 Xiamen INNOBIOMAX Biotechnology Co., Ltd.  ALL Rights Reserved. ICP Number:
2022014557-1
WeChat